The following paper focuses on Alzheimer’s disease, the disease which is a devastating brain disease and is one of the most typical forms of dementia, a general term that is most commonly used for memory loss and the diminishing in mental and physical abilities. It is most frequently diagnosed in the elderly although there have been some cases of the disease affecting people of middle age. There is not one known single cause for Alzheimer 's, however, scientists believe that due to the structural and chemical changes in the brain eventually gradually destroy brain cells thus effecting reasoning, learning and memory. If it continues to advance, the result is body failure. The disease affects the body in different stages, and as the stages become higher the symptoms become worse. Though the disease is incurable there are medications that can keep symptoms under control, and help the individual maintain a regular lifestyle.
Alzheimer’s Disease
The overall purpose is to provide an explanation of Alzheimer’s disease and its stages. Alzheimer’s disease affects the elderly, and in some rare cases individuals that are in their middle ages. The disease’s severity is diagnosed by stages. The higher the stage the worse the symptoms can be. In the first stages, friends and family members might notice changes in behavior, mood and communication patterns. Most common signs of the first stage include forgetting events and social withdrawal and forgetting where things are placed. During the middle stages of Alzheimer 's, the main sign is being unable to perform daily task and needing assistance. A person in this stage has decreased judgment and skills in maintaining good hygiene. The individual’s memory will become worse. However, they can recall their own name, but may have trouble remembering family members and can become disoriented. The main symptom, which occurs in, the late stages of Alzheimer’s, is severe personality and behavior changes. According to the
References: Bennett, 2006; Morris, 1996; Petersen, 2004; Price,2009; Rubin, 1998; Storandt, 2008) The neural substrates of semantic memory deficits in early Alzheimer’s disease: Clues from semantic priming effects and FDG-PET. Neuropsychologia, 55, 1657–1666.